The global PD-1 Inhibitor market size was valued at US$ 28.9 billion in 2024 and is projected to reach US$ 54.6 billion by 2030, at a CAGR of 11.2% during the forecast period 2024-2030.
United States PD-1 Inhibitor market size was valued at US$ 9.4 billion in 2024 and is projected to reach US$ 17.1 billion by 2030, at a CAGR of 10.5% during the forecast period 2024-2030.
Immunotherapy drugs that target the PD-1 pathway to enhance T-cell immune responses against cancer cells.
Strong growth driven by expanding indications across multiple cancer types. Increasing use in combination therapies and earlier lines of treatment. Ongoing research into biomarkers for improved patient selection.
Report Overview
This report provides a deep insight into the global PD-1 Inhibitor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 Inhibitor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 Inhibitor market in any manner.
Global PD-1 Inhibitor Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Merck
- Novartis
- Onxeo
- Sumitomo Dainippon Pharma
- Taiwan Liposome Company
- Tiziana Life Sciences
- Genentech (Roche)
- AstraZeneca
- Pfizer
Market Segmentation (by Type)
- Pembrolizumab
- Nivolumab
- Atezolizumab
- Durvalumab
- Avelumab
- Other
Market Segmentation (by Application)
- Melanoma
- Non-small Cell Lung Cancer (NSCLC)
- Urothelial Carcinoma
- Classical Hodgkin Lymphoma
- Renal Cell Carcinoma
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the PD-1 Inhibitor Market
- Overview of the regional outlook of the PD-1 Inhibitor Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PD-1 Inhibitor
1.2 Key Market Segments
1.2.1 PD-1 Inhibitor Segment by Type
1.2.2 PD-1 Inhibitor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 Inhibitor Market Overview
2.1 Global Market Overview
2.1.1 Global PD-1 Inhibitor Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 Inhibitor Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 Inhibitor Market Competitive Landscape
3.1 Global PD-1 Inhibitor Sales by Manufacturers (2019-2024)
3.2 Global PD-1 Inhibitor Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 Inhibitor Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 Inhibitor Sales Sites, Area Served, Product Type
3.6 PD-1 Inhibitor Market Competitive Situation and Trends
3.6.1 PD-1 Inhibitor Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 Inhibitor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 Inhibitor Industry Chain Analysis
4.1 PD-1 Inhibitor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of PD-1 Inhibitor Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 Inhibitor Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 Inhibitor Sales Market Share by Type (2019-2024)
6.3 Global PD-1 Inhibitor Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 Inhibitor Price by Type (2019-2024)
7 PD-1 Inhibitor Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 Inhibitor Market Sales by Application (2019-2024)
7.3 Global PD-1 Inhibitor Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 Inhibitor Sales Growth Rate by Application (2019-2024)
8 PD-1 Inhibitor Market Segmentation by Region
8.1 Global PD-1 Inhibitor Sales by Region
8.1.1 Global PD-1 Inhibitor Sales by Region
8.1.2 Global PD-1 Inhibitor Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 Inhibitor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 Inhibitor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 Inhibitor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 Inhibitor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 Inhibitor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck PD-1 Inhibitor Basic Information
9.1.2 Merck PD-1 Inhibitor Product Overview
9.1.3 Merck PD-1 Inhibitor Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck PD-1 Inhibitor SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Novartis
9.2.1 Novartis PD-1 Inhibitor Basic Information
9.2.2 Novartis PD-1 Inhibitor Product Overview
9.2.3 Novartis PD-1 Inhibitor Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis PD-1 Inhibitor SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Onxeo
9.3.1 Onxeo PD-1 Inhibitor Basic Information
9.3.2 Onxeo PD-1 Inhibitor Product Overview
9.3.3 Onxeo PD-1 Inhibitor Product Market Performance
9.3.4 Onxeo PD-1 Inhibitor SWOT Analysis
9.3.5 Onxeo Business Overview
9.3.6 Onxeo Recent Developments
9.4 Sumitomo Dainippon Pharma
9.4.1 Sumitomo Dainippon Pharma PD-1 Inhibitor Basic Information
9.4.2 Sumitomo Dainippon Pharma PD-1 Inhibitor Product Overview
9.4.3 Sumitomo Dainippon Pharma PD-1 Inhibitor Product Market Performance
9.4.4 Sumitomo Dainippon Pharma Business Overview
9.4.5 Sumitomo Dainippon Pharma Recent Developments
9.5 Taiwan Liposome Company
9.5.1 Taiwan Liposome Company PD-1 Inhibitor Basic Information
9.5.2 Taiwan Liposome Company PD-1 Inhibitor Product Overview
9.5.3 Taiwan Liposome Company PD-1 Inhibitor Product Market Performance
9.5.4 Taiwan Liposome Company Business Overview
9.5.5 Taiwan Liposome Company Recent Developments
9.6 Tiziana Life Sciences
9.6.1 Tiziana Life Sciences PD-1 Inhibitor Basic Information
9.6.2 Tiziana Life Sciences PD-1 Inhibitor Product Overview
9.6.3 Tiziana Life Sciences PD-1 Inhibitor Product Market Performance
9.6.4 Tiziana Life Sciences Business Overview
9.6.5 Tiziana Life Sciences Recent Developments
9.7 Genentech (Roche)
9.7.1 Genentech (Roche) PD-1 Inhibitor Basic Information
9.7.2 Genentech (Roche) PD-1 Inhibitor Product Overview
9.7.3 Genentech (Roche) PD-1 Inhibitor Product Market Performance
9.7.4 Genentech (Roche) Business Overview
9.7.5 Genentech (Roche) Recent Developments
9.8 AstraZeneca
9.8.1 AstraZeneca PD-1 Inhibitor Basic Information
9.8.2 AstraZeneca PD-1 Inhibitor Product Overview
9.8.3 AstraZeneca PD-1 Inhibitor Product Market Performance
9.8.4 AstraZeneca Business Overview
9.8.5 AstraZeneca Recent Developments
9.9 Pfizer
9.9.1 Pfizer PD-1 Inhibitor Basic Information
9.9.2 Pfizer PD-1 Inhibitor Product Overview
9.9.3 Pfizer PD-1 Inhibitor Product Market Performance
9.9.4 Pfizer Business Overview
9.9.5 Pfizer Recent Developments
10 PD-1 Inhibitor Market Forecast by Region
10.1 Global PD-1 Inhibitor Market Size Forecast
10.2 Global PD-1 Inhibitor Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 Inhibitor Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 Inhibitor Market Size Forecast by Region
10.2.4 South America PD-1 Inhibitor Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 Inhibitor by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global PD-1 Inhibitor Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 Inhibitor by Type (2025-2030)
11.1.2 Global PD-1 Inhibitor Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 Inhibitor by Type (2025-2030)
11.2 Global PD-1 Inhibitor Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 Inhibitor Sales (K Units) Forecast by Application
11.2.2 Global PD-1 Inhibitor Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 Inhibitor Market Size Comparison by Region (M USD)
Table 5. Global PD-1 Inhibitor Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global PD-1 Inhibitor Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 Inhibitor Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 Inhibitor Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 Inhibitor as of 2022)
Table 10. Global Market PD-1 Inhibitor Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 Inhibitor Sales Sites and Area Served
Table 12. Manufacturers PD-1 Inhibitor Product Type
Table 13. Global PD-1 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 Inhibitor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 Inhibitor Market Challenges
Table 22. Global PD-1 Inhibitor Sales by Type (K Units)
Table 23. Global PD-1 Inhibitor Market Size by Type (M USD)
Table 24. Global PD-1 Inhibitor Sales (K Units) by Type (2019-2024)
Table 25. Global PD-1 Inhibitor Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 Inhibitor Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 Inhibitor Market Size Share by Type (2019-2024)
Table 28. Global PD-1 Inhibitor Price (USD/Unit) by Type (2019-2024)
Table 29. Global PD-1 Inhibitor Sales (K Units) by Application
Table 30. Global PD-1 Inhibitor Market Size by Application
Table 31. Global PD-1 Inhibitor Sales by Application (2019-2024) & (K Units)
Table 32. Global PD-1 Inhibitor Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 Inhibitor Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 Inhibitor Market Share by Application (2019-2024)
Table 35. Global PD-1 Inhibitor Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 Inhibitor Sales by Region (2019-2024) & (K Units)
Table 37. Global PD-1 Inhibitor Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 Inhibitor Sales by Country (2019-2024) & (K Units)
Table 39. Europe PD-1 Inhibitor Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific PD-1 Inhibitor Sales by Region (2019-2024) & (K Units)
Table 41. South America PD-1 Inhibitor Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa PD-1 Inhibitor Sales by Region (2019-2024) & (K Units)
Table 43. Merck PD-1 Inhibitor Basic Information
Table 44. Merck PD-1 Inhibitor Product Overview
Table 45. Merck PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck PD-1 Inhibitor SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Novartis PD-1 Inhibitor Basic Information
Table 50. Novartis PD-1 Inhibitor Product Overview
Table 51. Novartis PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis PD-1 Inhibitor SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Onxeo PD-1 Inhibitor Basic Information
Table 56. Onxeo PD-1 Inhibitor Product Overview
Table 57. Onxeo PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Onxeo PD-1 Inhibitor SWOT Analysis
Table 59. Onxeo Business Overview
Table 60. Onxeo Recent Developments
Table 61. Sumitomo Dainippon Pharma PD-1 Inhibitor Basic Information
Table 62. Sumitomo Dainippon Pharma PD-1 Inhibitor Product Overview
Table 63. Sumitomo Dainippon Pharma PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Sumitomo Dainippon Pharma Business Overview
Table 65. Sumitomo Dainippon Pharma Recent Developments
Table 66. Taiwan Liposome Company PD-1 Inhibitor Basic Information
Table 67. Taiwan Liposome Company PD-1 Inhibitor Product Overview
Table 68. Taiwan Liposome Company PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Taiwan Liposome Company Business Overview
Table 70. Taiwan Liposome Company Recent Developments
Table 71. Tiziana Life Sciences PD-1 Inhibitor Basic Information
Table 72. Tiziana Life Sciences PD-1 Inhibitor Product Overview
Table 73. Tiziana Life Sciences PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Tiziana Life Sciences Business Overview
Table 75. Tiziana Life Sciences Recent Developments
Table 76. Genentech (Roche) PD-1 Inhibitor Basic Information
Table 77. Genentech (Roche) PD-1 Inhibitor Product Overview
Table 78. Genentech (Roche) PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Genentech (Roche) Business Overview
Table 80. Genentech (Roche) Recent Developments
Table 81. AstraZeneca PD-1 Inhibitor Basic Information
Table 82. AstraZeneca PD-1 Inhibitor Product Overview
Table 83. AstraZeneca PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Recent Developments
Table 86. Pfizer PD-1 Inhibitor Basic Information
Table 87. Pfizer PD-1 Inhibitor Product Overview
Table 88. Pfizer PD-1 Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Business Overview
Table 90. Pfizer Recent Developments
Table 91. Global PD-1 Inhibitor Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global PD-1 Inhibitor Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America PD-1 Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America PD-1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe PD-1 Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe PD-1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific PD-1 Inhibitor Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific PD-1 Inhibitor Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America PD-1 Inhibitor Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America PD-1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa PD-1 Inhibitor Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa PD-1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global PD-1 Inhibitor Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global PD-1 Inhibitor Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global PD-1 Inhibitor Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global PD-1 Inhibitor Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global PD-1 Inhibitor Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of PD-1 Inhibitor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 Inhibitor Market Size (M USD), 2019-2030
Figure 5. Global PD-1 Inhibitor Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 Inhibitor Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 Inhibitor Market Size by Country (M USD)
Figure 11. PD-1 Inhibitor Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 Inhibitor Revenue Share by Manufacturers in 2023
Figure 13. PD-1 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 Inhibitor Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 Inhibitor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 Inhibitor Market Share by Type
Figure 18. Sales Market Share of PD-1 Inhibitor by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 Inhibitor by Type in 2023
Figure 20. Market Size Share of PD-1 Inhibitor by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 Inhibitor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 Inhibitor Market Share by Application
Figure 24. Global PD-1 Inhibitor Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 Inhibitor Sales Market Share by Application in 2023
Figure 26. Global PD-1 Inhibitor Market Share by Application (2019-2024)
Figure 27. Global PD-1 Inhibitor Market Share by Application in 2023
Figure 28. Global PD-1 Inhibitor Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 Inhibitor Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America PD-1 Inhibitor Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada PD-1 Inhibitor Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 Inhibitor Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe PD-1 Inhibitor Sales Market Share by Country in 2023
Figure 37. Germany PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific PD-1 Inhibitor Sales and Growth Rate (K Units)
Figure 43. Asia Pacific PD-1 Inhibitor Sales Market Share by Region in 2023
Figure 44. China PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America PD-1 Inhibitor Sales and Growth Rate (K Units)
Figure 50. South America PD-1 Inhibitor Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa PD-1 Inhibitor Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa PD-1 Inhibitor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa PD-1 Inhibitor Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global PD-1 Inhibitor Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global PD-1 Inhibitor Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 Inhibitor Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 Inhibitor Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 Inhibitor Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 Inhibitor Market Share Forecast by Application (2025-2030)
